{"id":472156,"date":"2021-04-06T16:08:42","date_gmt":"2021-04-06T20:08:42","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=472156"},"modified":"2021-04-06T16:08:42","modified_gmt":"2021-04-06T20:08:42","slug":"regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/","title":{"rendered":"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n TARRYTOWN, N.Y.<\/span>, April 6, 2021<\/span> \/PRNewswire\/ —\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0<\/b>REGN)\u00a0today announced that it will report its first quarter 2021 financial and operating results on Thursday, May 6, 2021<\/span>, before the U.S. financial markets open. \u00a0The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time<\/span> that day.<\/p>\n

\n Conference Call Information
<\/b>To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7794757.\u00a0A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm<\/a>. A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days.\u00a0 <\/p>\n

\n About<\/b>\u00a0Regeneron
<\/b>Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.<\/p>\n

Regeneron is accelerating and improving the traditional drug development process through our proprietary\u00a0VelociSuite\u00ae<\/sup><\/i>\u00a0technologies, such as\u00a0VelocImmune\u00ae<\/sup><\/i>, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.<\/p>\n

For additional information about the company, please visit\u00a0www.regeneron.com<\/a>\u00a0or follow @Regeneron on Twitter.<\/p>\n

\n Contact Information:
<\/b>Investor Relations
Justin Holko<\/span>
914.847.7786
justin.holko@regeneron.com<\/a><\/p>\n

Corporate Communications
Hala Mirza<\/span>
914.847.3422
hala.mirza@regeneron.com<\/a><\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021-301263387.html<\/a><\/p>\n

SOURCE Regeneron Pharmaceuticals<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire TARRYTOWN, N.Y., April 6, 2021 \/PRNewswire\/ —\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN)\u00a0today announced that it will report its first quarter 2021 financial and operating results on Thursday, May 6, 2021, before the U.S. financial markets open. \u00a0The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call InformationTo access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7794757.\u00a0A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm. A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days.\u00a0 About\u00a0RegeneronRegeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for … <\/p>\n

Continue reading “Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-472156","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nRegeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TARRYTOWN, N.Y., April 6, 2021 \/PRNewswire\/ —\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN)\u00a0today announced that it will report its first quarter 2021 financial and operating results on Thursday, May 6, 2021, before the U.S. financial markets open. \u00a0The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call InformationTo access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7794757.\u00a0A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm. A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days.\u00a0 About\u00a0RegeneronRegeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for … Continue reading "Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-06T20:08:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY31962&sd=2021-04-06\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021\",\"datePublished\":\"2021-04-06T20:08:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/\"},\"wordCount\":321,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY31962&sd=2021-04-06\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/\",\"name\":\"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY31962&sd=2021-04-06\",\"datePublished\":\"2021-04-06T20:08:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY31962&sd=2021-04-06\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=NY31962&sd=2021-04-06\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021 - Market Newsdesk","og_description":"PR Newswire TARRYTOWN, N.Y., April 6, 2021 \/PRNewswire\/ —\u00a0Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN)\u00a0today announced that it will report its first quarter 2021 financial and operating results on Thursday, May 6, 2021, before the U.S. financial markets open. \u00a0The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call InformationTo access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International), conference ID 7794757.\u00a0A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at http:\/\/investor.regeneron.com\/events.cfm. A replay of the conference call and webcast will be archived on the Company’s website for at least 30 days.\u00a0 About\u00a0RegeneronRegeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for … Continue reading \"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-06T20:08:42+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY31962&sd=2021-04-06","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021","datePublished":"2021-04-06T20:08:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/"},"wordCount":321,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY31962&sd=2021-04-06","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/","name":"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY31962&sd=2021-04-06","datePublished":"2021-04-06T20:08:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY31962&sd=2021-04-06","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY31962&sd=2021-04-06"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-to-report-first-quarter-2021-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-6-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron to Report First Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=472156"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/472156\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=472156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=472156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=472156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}